Innovent Biologics Inc (IVBXF) company profile
IVBXFOTC
$12.20−0.30 (-2.43%)
Close on Oct 19, 2026Market cap –P/E –Yield –
About Innovent Biologics
Innovent Biologics Inc is listed on OTC under the ticker IVBXF.
Company profile
Company
- Legal name
- Innovent Biologics Inc
- Headquarters
- New York, NY
- Address
- 120 Broadway, 32nd Floor 10271
- Phone
- (212) 238-3000
Stock & identifiers
- Ticker
- IVBXF
- Exchange
- OTC
- IPO date
- Sep 4, 2019
- SEC CIK
- 1774163
- FIGI
- BBG00PDF9MQ0
- Share class FIGI
- BBG00M8832C4
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Innovent Biologics's leadership is listed in its proxy statement (Form DEF 14A).
See a number that looks wrong?